Thermo Fisher to Acquire Clario Holdings for $8.88B

Thermo Fisher Scientific Inc. agreed to buy clinical trial data solutions company Clario Holdings Inc. from a shareholder group led by Astorg Asset Management, Nordic Capital, Novo Holdings, and Cinven for $8.88 billion in cash.

“Thermo Fisher Scientific Inc. agreed to buy clinical trial data solutions company Clario Holdings Inc. from a shareholder group led by Astorg Asset Management SARL, Nordic Capital, Novo Holdings A/S and Cinven Ltd. for $8.88 billion in cash.”

Signals are extracted from public coverage and print archives and pinned to a verbatim quote, presented as reported by their sources; naming a company in a signal is not an accusation against it. The verified mark denotes a high-confidence, corroborated signal. See our methodology and legal notes.